Clinical Trials on Lipidomics
Total 21 results
-
Benjamin GollaschCompletedHemodialysis | Lipidomics | Fatty Acid Metabolism | ErythrocytesGermany
-
Monash University MalaysiaRecruiting
-
Imperial College LondonUniversity College London Hospitals; Northern Care Alliance NHS Foundation... and other collaboratorsRecruitingGastric Cancer | Oesophageal Cancer | Microbiome | Volatile Organic Compounds | Transcriptomics | Microbioata | Breath Analysis | Volatalomics | Metabonomics/Lipidomics | Microbiome AnalysisUnited Kingdom
-
University of TorontoUnknownCardiovascular Risk Factor | Cholesterol; LipidosisCanada
-
Children's Mercy Hospital Kansas CityRecruiting
-
Libbs Farmacêutica LTDACompletedArterial Hypertension | Blood Glucose, High | Cholesterol; LipidosisBrazil
-
University of AlicanteCompletedHypertension | Obesity | Body Weight | Diet, Healthy | Machine Learning | Cholesterol; LipidosisSpain
-
Kaohsiung Medical University Chung-Ho Memorial...RecruitingPain | Oxidative Stress | Fibromyalgia, Primary | Metabolomics | Soreness, Muscle | LipidomicsTaiwan
-
Sixth Affiliated Hospital, Sun Yat-sen UniversityNot yet recruitingInflammatory Bowel Diseases | Crohn Disease | Polyunsaturated Acid Lipidosis
-
University of TorontoUnknownCardiovascular Diseases | Stroke | Inflammation | Diabetes | Blood Pressure | Coronary Heart Disease | Adiposity | Cardiovascular Risk Factor | Cholesterol; LipidosisCanada
-
SanofiCompletedSphingomyelin LipidosisItaly, Czechia, Belgium, France, Portugal, Turkey, United States, Argentina, Brazil, Chile, Germany, Romania, Spain
-
Pamukkale UniversityBakirkoy Dr. Sadi Konuk Research and Training HospitalCompletedType2 Diabetes | Self Efficacy | Self Management | Cholesterol; Lipidosis | High Density Lipoprotein Deficiency | Motivational Interview | Tele-nursing | LDL - Low Density Lipoprotein Receptor DisorderTurkey
-
Genzyme, a Sanofi CompanyRecruitingGaucher Disease | Cerebroside Lipidosis Syndrome | Glucocerebrosidase Deficiency Disease | Glucosylceramide Beta-Glucosidase Deficiency DiseaseHungary, Croatia, United States, Australia, Belgium, Brazil, Bulgaria, Canada, Denmark, Germany, Greece, Hong Kong, India, Indonesia, Italy, Jordan, Korea, Republic of, Kuwait, Lebanon, Malaysia, Pakistan, Philippines, Poland, Saudi Arabia and more
-
Genzyme, a Sanofi CompanyCompletedSphingomyelin LipidosisUnited States, Argentina, Australia, Belgium, Brazil, Bulgaria, Chile, France, Germany, Italy, Japan, Netherlands, Portugal, Spain, Tunisia, Turkey, United Kingdom
-
Genzyme, a Sanofi CompanyCompletedSphingomyelin LipidosisUnited States, Belgium, Brazil, France, Germany, Italy, United Kingdom
-
Genzyme, a Sanofi CompanyCompletedGaucher Disease, Type 1 | Cerebroside Lipidosis Syndrome | Glucocerebrosidase Deficiency Disease | Glucosylceramide Beta-Glucosidase Deficiency Disease | Gaucher Disease, Non-Neuronopathic FormUnited States, Israel, Mexico, Russian Federation, Argentina, Italy
-
SanofiApproved for marketing
-
Genzyme, a Sanofi CompanyCompletedSphingomyelin LipidosisBrazil, France, Italy, United States, Germany, United Kingdom
-
Genzyme, a Sanofi CompanyCompletedGaucher Disease, Type 1 | Cerebroside Lipidosis Syndrome | Glucocerebrosidase Deficiency Disease | Glucosylceramide Beta-Glucosidase Deficiency Disease | Gaucher Disease, Non-Neuronopathic FormUnited States, United Kingdom, Spain, Italy, Brazil, Canada, Poland
-
Genzyme, a Sanofi CompanyCompletedCerebroside Lipidosis Syndrome | Glucosylceramide Beta-Glucosidase Deficiency Disease | Gaucher Disease Type I | Clucocerebrosidase Deficiency Disease | Gaucher Disease, Non-Neuronopathic FormUnited States
-
University of CopenhagenRigshospitalet, DenmarkRecruitingNeoplasms | Quality of Life | Insulin Resistance | Exercise | Body Composition | Sarcopenia | Cachexia | Physical Functional Performance | Muscle, Skeletal | Patient Reported Outcome Measures | Gastrointestinal Microbiome | Metabolism | Caregivers | Adipose Tissue | Proteomics | Mitochondria | Lipidomics | EpigenomicsDenmark